Drug profile · INN
ibritumomab tiuxetan
ZEVALIN
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
ibritumomab tiuxetan (ZEVALIN) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN ibritumomab tiuxetan
Brand ZEVALIN
Route INJECTION
Formulation INJECTABLE
ATC code V10XX02
Frequently asked questions
What is ibritumomab tiuxetan?
ibritumomab tiuxetan (ZEVALIN) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for ibritumomab tiuxetan?
ZEVALIN is a marketed brand name for ibritumomab tiuxetan. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ibritumomab tiuxetan?
ibritumomab tiuxetan has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.